Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for AbCellera Biologics Inc. (ABCL)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
2 days ago | The Motley Fool
2 days ago | Business Wire
a week ago | Business Wire
a week ago | Business Wire
3 weeks ago | Business Wire
a month ago | Business Wire
a month ago | Business Wire
2 months ago | Business Wire
3 months ago | Pulse2
3 months ago | Business Wire
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
Sector:
HealthcareIndustry:
BiotechnologyEmployees:
206Address:
AbCellera Biologics Inc. 2215 Yukon Street Vancouver BC V5Y 0A1 CanadaWebsite:
Home